PUBLIC CONTRACT · 2023
Medicamentos Antirretroviricos
- Contract value
- €26,129.70
- Signed on
- 6 September 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10699067PUBLISHED DESCRIPTION
41/56/2024
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- MYLAN, LDA · Tax ID 502248793
- Awardee
- FARMOZ · Tax ID 501505334
- Awardee
- Generis Farmacêutica, S.A. · Tax ID 508107997
- Bidder
- Abbvie, Lda. · Tax ID 510229050
- Bidder
- GILEAD SCIENCES, LDA · Tax ID 503604704
- Bidder
- ViiV Healthcare, Unipessoal Lda · Tax ID 509117961
- Bidder
- Teva Pharma - Produtos Farmacêuticos · Tax ID 507045491
Values and timeline
- Contract price
- €26,129.70
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 3 May 2024
- Award date
- 6 September 2023
- Signing date
- 6 September 2023
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6637385
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.